1. 紫癜性肾炎患儿血清 Gd-IgA1、sFlt-1、IgA/C3 比值与肾损伤 和疗效的关系研究.
- Author
-
毛 露, 伍 岳, 李 莎, 舒秀兰, and 赵 斐
- Subjects
- *
TREATMENT effectiveness , *NEPHRITIS , *WOUNDS & injuries - Abstract
Objective: To investigate the relationship between serum galactose-deficient immunoglobulin A1 (Gd IgA1), soluble fms like tyrosine kinase receptor l (sFlt-1), immunoglobulin A (IgA) /complement C3 (C3) ratio, renal injury, and therapeutic effect in children with purpura nephritis (HSPN) . Methods: A total of 151 children diagnosed with HSPN in the The Affiliated Hospital of Chengdu University were selected from December 2019 to December 2021 as the case group. Another 100 healthy volunteer children who underwent physical examinations during the same period were selected as the control group. The serum Gd-IgA1, sFlt-1, IgA/C3 ratio, renal function index [urea nitrogen (BUN), blood creatinine (Scr), 24 h urinary protein (UP) quantification (24hUPE) and UP/Scr] between the two groups were compared. Pearson correlation analysis was used to investigate the correlation between serum Gd-IgA1, sFlt-1, IgA/C3ratio and renal function indicators. The serum Gd-IgA1, sFlt-1, and IgA/C3 ratios of children with different renal pathological grades and different therapeutic effects were compared. Results: The Gd-IgA1, sFlt-1, IgA/C3 ratio, BUN, Scr, 24hUPE and UP/Scr of the case group were all higher than those of the control group (P<0.05) . Pearson correlation analysis showed: Gd-IgA1, sFlt-1, IgA/C3 ratios were positively correlated with BUN, Scr, 24hUPE and UP/Scr (P<0.05) . With the elevated renal pathological grade, the serum Gd-IgA1,sFlt-1, and IgA/C3 ratios in HSPN patients continue to increase (P<0.05) . The Gd-IgA1, sFlt-1, and IgA/C3 ratios of the invalid group were higher than those of the valid group (P<0.05) . Conclusion: Gd-IgA1, sFlt-1, and IgA/C3 ratios are involved in the disease progression in children with HSPN, which can lead to renal injury, aggravate renal pathological changes, clinical guidance for treatment can be based on changes in the above indicators. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF